Literature DB >> 19540557

3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.

Francesc Alameda1, Blanca Espinet, Cristina Corzo, Raquel Muñoz, Beatriz Bellosillo, Belén Lloveras, Lara Pijuan, Javier Gimeno, Marta Salido, Francesc Solé, Ramon Carreras, Sergi Serrano.   

Abstract

Gains of 3q26 chromosome region, where the human telomerase RNA gene (hTERC) is located, have been previously documented in cervical carcinomas and preneoplastic lesions. The aim of our study was to define the value of 3q26 gains related to persistence-progression in cervical specimens with cytologic diagnosis for low-grade squamous intraepithelial lesions, using liquid-based cytology (ThinPrep; Hologic, Marlborough, MA) and fluorescence in situ hybridization. For these purposes, 55 patients were included in the study: 25 cases with a negative cytologic diagnosis for squamous intraepithelial lesion or malignancy (20 premenopausal and 5 postmenopausal women, used as control negative cases) and 30 low-grade squamous intraepithelial lesion cases. The follow-up was performed using cytology at 6, 12, and 24 months after the low-grade squamous intraepithelial lesion diagnosis. When the cytology result showed a high-grade lesion, colposcopy and biopsy were performed. Fluorescence in situ hybridization technique with a 3q26 2-color commercial probe was performed to determine the number of hTERC copies. There were no differences between premenopausal and postmenopausal normal cases. Low-grade squamous intraepithelial lesion cases with regression in the follow-up at 6, 12, and 24 months showed a percentage of cells with 3q26 gains similar to the control cases and lower than low-grade squamous intraepithelial lesion cases with persistence or progression (P < .05). Fluorescence in situ hybridization results were similar in preserved and frozen samples. However, in frozen samples, the number of cells suitable to be evaluated by fluorescence in situ hybridization was lower than in preserved (nonfrozen) cases. In conclusion, the determination by fluorescence in situ hybridization of 3q26 gains in low-grade squamous intraepithelial lesion cases could be useful to predict the persistence-progression of such cervical lesions using both preserved and frozen cervical material.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540557     DOI: 10.1016/j.humpath.2009.03.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.

Authors:  Jing Jiang; Li-Hui Wei; Ya-Li Li; Rui-Fang Wu; Xing Xie; You-Ji Feng; Guo Zhang; Chao Zhao; Yun Zhao; Zhong Chen
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

2.  Analysis of genetic copy number changes in cervical disease progression.

Authors:  Frank A Policht; Minghao Song; Svetlana Sitailo; Anna O'Hare; Raheela Ashfaq; Carolyn Y Muller; Larry E Morrison; Walter King; Irina A Sokolova
Journal:  BMC Cancer       Date:  2010-08-16       Impact factor: 4.430

3.  Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value.

Authors:  M I Lomnytska; S Becker; I Bodin; A Olsson; K Hellman; A-C Hellström; M Mints; U Hellman; G Auer; S Andersson
Journal:  Br J Cancer       Date:  2010-11-30       Impact factor: 7.640

4.  Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.

Authors:  Oscar Vazquez-Mena; Ingrid Medina-Martinez; Eligia Juárez-Torres; Valeria Barrón; Ana Espinosa; Nicolás Villegas-Sepulveda; Laura Gómez-Laguna; Karem Nieto-Martínez; Lorena Orozco; Edgar Roman-Basaure; Sergio Muñoz Cortez; Manuel Borges Ibañez; Carlos Venegas-Vega; Mariano Guardado-Estrada; Angélica Rangel-López; Susana Kofman; Jaime Berumen
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

5.  Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical Cancer.

Authors:  Huang Bin; Wu Ruifang; Li Ruizhen; Liang Yiheng; Liu Zhihong; Li Juan; Wang Chun; Zhou Yanqiu; Weng Leiming
Journal:  Iran J Basic Med Sci       Date:  2013-06       Impact factor: 2.699

6.  CLDN1 expression in cervical cancer cells is related to tumor invasion and metastasis.

Authors:  Wei-Na Zhang; Wei Li; Xiao-Li Wang; Zheng Hu; Da Zhu; Wen-Cheng Ding; Dan Liu; Ke-Zhen Li; Ding Ma; Hui Wang
Journal:  Oncotarget       Date:  2016-12-27

7.  3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.

Authors:  Erica R Heitmann; Kamani M Lankachandra; Jeff Wall; George D Harris; Hollie J McKinney; G Reza Jalali; Yogita Verma; Eric Kershnar; Michael W Kilpatrick; Petros Tsipouras; Diane M Harper
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

8.  Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: a genome-wide follow-up study.

Authors:  Ingrid Medina-Martinez; Valeria Barrón; Edgar Roman-Bassaure; Eligia Juárez-Torres; Mariano Guardado-Estrada; Ana María Espinosa; Miriam Bermudez; Fernando Fernández; Carlos Venegas-Vega; Lorena Orozco; Edgar Zenteno; Susana Kofman; Jaime Berumen
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

Review 9.  Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.

Authors:  Margot M Koeneman; Irene T Ovestad; Emiel A M Janssen; Monique Ummelen; Roy F P M Kruitwagen; Anton H Hopman; Arnold J Kruse
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.